Skip to search.
 TSX Up 0.14% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
5.51 Down 2.49(31.12%) Apr 15, 3:59PM EDT
Add to Portfolio
Prev Close:8.00
Open:7.90
Bid:5.80
Ask:5.80
1y Target Est:N/A
Beta:0.66
Next Earnings Date:N/A
Day's Range:5.01 - 7.90
52wk Range:1.95 - 9.25
Volume:103,845
Avg Vol (3m):9,089
Market Cap:163.12M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Must Read

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.27
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-14) :-0.71
Quarterly EPS Est (Mar-14) :-0.11
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, develops therapeutics for various disease indications primarily in Canada. Its lead CNS drug candidate includes ELND005, a Phase II clinical trial product for the treatment of Alzheimer... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback